NASDAQ
1.01USD
+0.02 (+1.70%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
78.2M
P/E
—
EPS
—
Beta
1.44
52W range
0.76-3.31
Day range
1.00–1.06
Open
1.01
Prev close
1.00
Volume
544K
Avg volume
1.3M
Dividend
0.00
IPO
2004-07-27
https://www.globenewswire.com/news-release/2026/05/21/3299771/0/en/Cardiff-Oncology-Announces-Webcast-to-Discuss-Updated-Phase-2-CRDF-004-Data-for-Onvansertib-in-First-Line-RAS-Mutated-mCRC.html · 5/21/2026+0.40
https://seekingalpha.com/article/4859202-cardiff-oncology-what-storms-can-we-expect-in-2026-the-case-for-measured-enthusiasm · 1/13/2026-0.30
https://seekingalpha.com/article/4833398-cardiff-oncology-preparing-for-a-defining-2026 · 10/25/2025+0.60
Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
